What is Wall Street's Target Price for Jounce Therapeutics Inc (JNCE) Stock Monday?

Wall Street is positive on Jounce Therapeutics Inc (JNCE). On average, analysts give the stock a Buy rating. The average price target is $6, which means analysts expect the stock to add by 226.09% over the next twelve months.That average ranking earns the stock an Analyst Rating of 26, which is better than 26% of stocks ba